-
LUNGevity Foundation Invests $1.2 Million to Fuel Next Generation of Lung Cancer Research
Read time: 6 minutes. LUNGevity Foundation announced $1.2 million in research awards that are designed to strengthen the lung cancer workforce and accelerate progress across the -
Reaping the Rewards of Radiation to Make Immunotherapy More Effective
Read time: 3 minutes. Immune checkpoint inhibitors (ICIs) have revolutionized the way we approach lung cancer treatment over the past decade. These lifesaving drugs block the PD-L1 -
Aiming for a Cure: How CD74 Research Could Eliminate Drug-Resistant Lung Cancer for Good
Read time: 4 minutes. Lung cancer remains the leading cause of cancer death worldwide. Over the past two decades, the development of targeted therapies, particularly tyrosine -
Researcher Goes Against the Grain: Brings New Hope for Patients with BRAF Fusions
Read time: 4 minutes. BRAF is an important signaling protein that regulates how normal cells grow and multiply through the MAPK (mitogen activated protein kinase) signaling pathway -
Advancing Lung Cancer Screening in Veterans Through Strategic Research
Read time: 4 minutes. Lung cancer screening has the potential to save more lives than any other cancer screening tool, yet reports suggest only 10%–20% of eligible patients are -
Low-Dose Computed Tomography and Beyond: Advances in the Early Detection of Lung Cancer
Read time: 5 minutes. Lung cancer screening has come a long way since low-dose CT (LDCT) scans first became available in 2015 in the United States. However, LDCTs can still miss